63 Moons Share Price Surge 14% on NCLT Approval of NSEL Settlement Scheme

Shares of 63 Moons Technologies witnessed a sharp 14% jump on November 28, 2025, following the approval of the National Spot Exchange Limited (NSEL) settlement scheme by the National Company Law Tribunal (NCLT). This long-anticipated regulatory nod sets the stage for financial closure and resolution for thousands of affected traders.
₹1,950 Crore Settlement Plan Greenlit by NCLT
The NCLT has formally approved a ₹1,950 crore settlement scheme filed by NSEL, backed by its parent company, 63 Moons Technologies.
As per the scheme, this amount will be distributed among 5,682 traders in proportion to their outstanding dues as of July 31, 2024. The scheme seeks to provide a full and final resolution to claims arising from the default crisis that hit NSEL over a decade ago.
Origins of the Settlement Proposal
The settlement scheme was initially proposed by the NSEL Investors Forum (NIF), which represents a significant base of the affected trading community.
The plan was later submitted to the NCLT by NSEL with support from 63 Moons Technologies, reflecting their commitment to resolve the prolonged matter amicably.
This is not the first instance of relief extended to investors. Back in August 2013, approximately ₹179 crore was disbursed to assist 7,053 smaller traders, each with dues less than ₹10 lakh.
Read More: GMDC Share Price Surge Over 9% as Rare Earth Magnet Incentive Plan Gets Approved!
63 Moons Technologies Share Price Performance
As of November 28, 2025, at 11:47 AM, 63 Moons Technologies share price on NSE was trading at ₹893.00 up by 14.28% from the previous closing price.
Conclusion
The NCLT’s approval of the ₹1,950 crore settlement scheme brings long-awaited closure to the NSEL episode. With the settlement covering 5,682 traders, this represents a major milestone for 63 Moons Technologies and its stakeholders.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 28, 2025, 2:38 PM IST

Team Angel One
- Adani Defence Signs Five-Year Ammunition Supply Agreement for AK-203 Programme
- AstraZeneca Gains FDA Approval for Camizestrant Combo in ESR1-Mutated Advanced Breast Cancer
- CBI Files FIR Against Subhash Chandra Over LIC Housing Finance Loan Fraud Allegations
- Top Gainers and Losers on September 3, 2026: Adani Ports, Axis Bank and HDFC Bank Rise Up to 2%
- Hilton Expands India Presence With 60 Hotels Under Construction, Plans 400 More Properties


